on Methapharm
Methapharm Announces Partnership With Bosch
Methapharm Respiratory, a global leader in respiratory diagnostics, has announced a new partnership with Bosch Healthcare Solutions. Bosch, a subsidiary of Robert Bosch GmbH, is known for its technological expertise and dedication to innovation.
The partnership will introduce the FDA-cleared Vivatmo Pro to the U.S. market. Vivatmo Pro is a device designed for point-of-care measurements of fractional exhaled nitric oxide (FeNO), an important marker for airway inflammation, particularly in asthma management. The device is non-invasive, easy to use, and virtually maintenance-free.
Craig Baxter, CEO of Methapharm, expressed excitement about the collaboration, highlighting Bosch's technological excellence. Marc Meier, General Manager of Bosch Healthcare Solutions, noted that Methapharm's approach aligns with Bosch's mission to improve healthcare quality and accessibility.
More information about Vivatmo Pro can be found on Methapharm Respiratory's website.
R. H.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Methapharm news